NeuroPace (NPCE) Interest & Investment Income (2021 - 2026)
NeuroPace's quarterly Interest & Investment Income came in at $565000.0 in Q1 2026, down 28.75% year-on-year from $793000.0 in Q1 2025, and down 11.44% quarter-over-quarter from $638000.0 in Q4 2025.
NeuroPace has reported Interest & Investment Income for 6 years, with the latest figure at $565000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 28.75% year-over-year to $565000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 13.44% YoY), and the FY2025 full-year result was $2.8 million, down 6.88% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $565000.0, down from $638000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $827000.0 in Q1 2024, with the low at $134000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $649000.0, with a median of $726000.0 recorded in 2023.
- Year-over-year, Interest & Investment Income soared 441.79% in 2023 and dropped 28.75% in 2026.
- Tracing NPCE's Interest & Investment Income over 5 years: stood at $800000.0 in 2022, then gained by 2.75% to $822000.0 in 2023, then decreased by 17.15% to $681000.0 in 2024, then decreased by 6.31% to $638000.0 in 2025, then decreased by 11.44% to $565000.0 in 2026.
- The last three Interest & Investment Income figures came in at $565000.0 (Q1 2026), $638000.0 (Q4 2025), and $667000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 565,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 638,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 718,000.00 |
| Mar 31, 2025 | 793,000.00 |
| Dec 31, 2024 | 681,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 762,000.00 |
| Mar 31, 2024 | 827,000.00 |
| Dec 31, 2023 | 822,000.00 |
| Sep 30, 2023 | 769,000.00 |
| Jun 30, 2023 | 733,000.00 |
| Mar 31, 2023 | 726,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 423,000.00 |
| Jun 30, 2022 | 221,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 136,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 26,000.00 |